Detalles de la búsqueda
1.
A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode.
Oncologist
; 29(6): e828-e836, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38206849
2.
Effect of exercise across the head and neck cancer continuum: a systematic review of randomized controlled trials.
Support Care Cancer
; 31(12): 670, 2023 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37924500
3.
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study.
Int J Mol Sci
; 23(15)2022 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35955679
4.
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.
Cancer Immunol Immunother
; 70(6): 1667-1678, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33315149
5.
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
Int J Mol Sci
; 22(1)2020 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33375194
6.
Exercise for counteracting post-acute COVID-19 syndrome in patients with cancer: an old but gold strategy?
Acta Oncol
; 61(3): 388-392, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34854782
7.
Exercise in men with prostate cancer: how to move on?
Support Care Cancer
; 30(12): 9703-9705, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35779134
8.
Feasibility of a novel exercise program for patients with breast cancer offering different modalities and based on patient preference.
Eur J Oncol Nurs
; 70: 102554, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615512
9.
What is the role of physical exercise in the era of cancer prehabilitation? A systematic review.
Crit Rev Oncol Hematol
; 198: 104350, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38642726
10.
Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study.
PLoS One
; 19(1): e0290792, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38271378
11.
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Eur J Cancer
; 202: 114006, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38489861
12.
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer.
Expert Opin Biol Ther
; 23(11): 1077-1087, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36995069
13.
Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody-Drug Conjugates.
Cancers (Basel)
; 15(22)2023 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001628
14.
Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors.
Crit Rev Oncol Hematol
; 184: 103929, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36773668
15.
Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study.
J Cancer Res Clin Oncol
; 149(7): 3435-3445, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35943598
16.
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories.
J Pers Med
; 13(10)2023 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37888038
17.
Exploring the feasibility of a combined exercise program for patients with advanced lung or pancreatic cancer.
Asia Pac J Oncol Nurs
; 10(Suppl 1): 100298, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38197044
18.
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report.
JTO Clin Res Rep
; 4(12): 100597, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38124787
19.
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients.
Cancers (Basel)
; 15(21)2023 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37958458
20.
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.
Oncoimmunology
; 12(1): 2253644, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37720688